MultiCare Health System

HomeBill PayMyChartJobsWays to HelpFor ProvidersFor Staff

• Research Institute
  • About Us
  • Anesthesiology
  • Cardiology
  • Cardiothoracic Surgery
    • Atrial Fibrillation
    • Carotid Stenting For High Surgical-Risk Patients - CHOICE
    • Heart Valve Study
     
  • Donation Information
  • Endocrinology & General Medicine
  • Gastroenterology
  • Genetics/Genomics
  • In-Patient Medicine
  • Interventional Neuroradiology
  • Neurology
  • Northwest Community Clinical Oncology Program
  • Oncology & Hematology
  • Other Research Programs
  • Research Institute Staff
  • Surgery
   
 

Heart Valve Study

Title: Clinical Trial of the On-X® Valve Using Low Dose Anticoagulation

Purpose: This study includes patients who will have their diseased heart valve replaced with the On-X mechanical heart valve. It is being done to determine whether lower levels of anticoagulation, including lower INR on Warfarin as well as Aspirin + Plavix only, can be used to prevent clotting events in patients who receive this particular mechanical heart valve.

To learn more about the On-X® Valve, click here.

Who Can Participate?

Diagnosis or Condition: Patients undergoing an aortic or mitral heart valve replacement

Age: 18 yrs or older

Sex: Males and Females

Visits: Yearly visits for up to 8 years. (4 visits the first year). Home INR meter management for patients on Coumadin

PI: Dennis Nichols, MD

Study Coordinator: Meredith (Janey) Barnhart 253.403.7258

For more information, contact the Study Coordinator and reference ON-X